Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipyc

The structure of the adduct formed in the reaction between Aubipyc,
a cytotoxic organogold(III) compound, and the model protein hen egg white
lysozyme (HEWL) has been solved by X-ray crystallography. It emerges that
Aubipyc, after interaction with HEWL, undergoes reduction of the gold(III) center followed by detaching of the cyclometalated ligand; the resulting naked gold(I) ion is found bound to the protein at Gln121. A direct comparison between the present structure and those previously solved for the lysozyme adducts with other gold(III) compounds demonstrates that coordinated ligands play a key role in the protein−metallodrug recognition process. Structural data support the view that gold(III)-based antitumor prodrugs are activated through metal reduction.